4//SEC Filing
Berman Robert 4
Accession 0001562180-20-004697
CIK 0001689813other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 9:49 PM ET
Size
11.4 KB
Accession
0001562180-20-004697
Insider Transaction Report
Form 4
Berman Robert
Chief Medical Officer
Transactions
- Sale
Common Shares
2020-06-23$75.05/sh−4,296$322,431→ 341 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-06-23−4,296→ 58,404 totalExercise: $0.61Exp: 2024-11-25→ Common Shares (4,296 underlying) - Exercise/Conversion
Common Shares
2020-06-23$0.61/sh+4,296$2,621→ 4,637 total
Holdings
- 550,000(indirect: By Trust)
Common Shares
- 240,500(indirect: By Trust)
Common Shares
- 50(indirect: By Spouse)
Common Shares
Footnotes (3)
- [F1]These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 - $75.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The option, representing a right to purchase a total of 225,000 shares, was granted on November 26, 2014, and vested in four equal installments on November 26, 2014, 2015, 2016 and 2017
Documents
Issuer
Biohaven Pharmaceutical Holding Co Ltd.
CIK 0001689813
Entity typeother
Related Parties
1- filerCIK 0001704483
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 9:49 PM ET
- Size
- 11.4 KB